US Patent
US8871938 — Process for making quinolone compounds
Composition of Matter · Assigned to Melinta Therapeutics Inc · Expires 2029-09-23 · 3y remaining
Vulnerability score
10/100
Ironclad — strong claim type, well-established, deep family
What this patent protects
This patent protects a process for synthesizing quinolone compounds with less than about 0.40% dimeric impurity.
USPTO Abstract
The present invention relates to the field of synthesizing anti-infective compounds. More particularly, the invention relates to synthesizing a family of quinolone compounds useful as anti-infective agents. The invention includes a process for preparing a quinolone compound wherein less than about 0.40% of dimeric impurity of the quinolone is produced.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.